Semaglutide

Semaglutide

What is it? Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist that mimics a naturally occurring hormone involved in appetite regulation, insulin release, and blood sugar control. It is approved in Canada and other countries under specific brand names for the treatment of type 2 diabetes and chronic weight management in eligible adults.

Potential Benefits

Supports weight loss by reducing appetite and increasing feelings of fullness

Helps improve blood sugar control in people with type 2 diabetes

May reduce food cravings and overall calorie intake

Slows stomach emptying, helping prolong satiety

May improve metabolic health when combined with diet and exercise

Has been shown to reduce cardiovascular risk in certain people with type 2 diabetes and in some people with obesity and cardiovascular disease

Typical Treatment Duration

Semaglutide is generally intended for long-term use when prescribed for chronic weight management or diabetes.

Treatment typically begins at a low dose, with gradual increases every 4 weeks to improve tolerability until the maintenance dose is reached.

The appropriate dose and duration should be determined by a healthcare professional based on the individual's medical needs and response.

Storage

Before first use: Refrigerate (2–8°C). Do not freeze.

After first use (manufacturer guidance varies by product): Follow the storage instructions for the specific product. Keep protected from excessive heat and light.